About Letbo
Letbo is a company based in Taipei (Taiwan) founded in 2019. Letbo offers products and services including Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Labturbo Biotech Corporation
-
Annual Revenue
$72.97 M-61.2as on Dec 31, 2024
-
Net Profit
$12.96 M0as on Dec 31, 2024
-
EBITDA
-$132.12 M2.56as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Letbo
Letbo is a publicly listed company on the TPEX with ticker symbol 7725 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Letbo
Letbo offers a comprehensive portfolio of products and services, including Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents.
Automated systems are utilized for efficient detection of pathogens and genetic markers, reducing errors in clinical diagnostics and research applications
Reagents are employed for high-purity extraction of RNA and DNA from various samples, ensuring integrity for downstream analyses in diagnostics and studies
Funding Insights of Letbo
Investments & Acquisitions by Letbo
Financial Statements - Letbo
Letbo Comparisons
Competitors of Letbo
Latest news on Letbo
Frequently Asked Questions about Letbo
Letbo was founded in 2019.
Letbo is headquartered in Taipei, Taiwan.
Chi Sheng Tai is the current CEO of Letbo.
Letbo was founded in 2019 in Taipei, Taiwan, within the biotechnology sector. Automated systems for nucleic acid detection are provided to support pathogen and genetic marker identification in clinical diagnostics and research settings. Efficiency and accuracy are improved while human error is minimized, yielding consistent outcomes. Reagents for high-purity RNA and DNA extraction from diverse samples are supplied, alongside high-sensitivity options for targeted pathogen and gene testing.
Letbo offers Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents.
Yes, Letbo is publicly traded on TPEX under the ticker symbol 7725.
The ticker symbol of Letbo is 7725 on TPEX.